HDAC9 and Alzheimer disease: Based on a recent literature review on the use of HDAC inhibitors for the treatment of AD [224], PD [234], ALS [235], and other NDD in animal models, it was found that HDAC inhibitors (HDACi) were able to enhance synaptic plasticity as well as cognitive and motor functions in the animals.